Search results for "xselect"

Fapon debuts AI-engineered molecular diagnostic enzymes and Alzheimer's disease assay solutions while expanding its North American IVD footprint

New U.S. business will combine automated diagnostic kit manufacturing, fulfillment, logistics and digital pathway technology to help laboratories and healthcare organizations scale testing programs

Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volumes, introducing a step-change in analytical performance for complex biological matrices

Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics

Thermo Fisher’s presence at ADLM 2026 reflects its ongoing commitment to addressing unmet clinical needs with reliable, purpose-built diagnostic and workflow solutions

Alps Dx introduces Xpressor™, a filtration and capping solution designed to simplify oral fluid sample preparation and improve preanalytical consistency

AI, precision diagnostics, and award-winning innovation take center stage

bioMérieux to showcase integrated microbiology, molecular diagnostics, mass spectrometry, and laboratory informatics solutions

At AAIC 2026, Dr. Ashton Harper, Roche Diagnostics, discusses how pTau217 could help reshape Alzheimer’s testing across primary and secondary care

G&H will highlight end-to-end diagnostic instrument development, photonics integration, and ISO 13485-certified manufacturing for next-generation IVDs and medical devices

Beta-site engagement begins as Pictor introduces an integrated 96-well workflow designed for scalable targeted protein analysis in research laboratories

The DxU 1800 System features new urine chemistry analyzer and consumables with market-leading microscopy helping laboratories to meet rising diagnostic demand

ADLM 2026 to explore diabetes milestones, space diagnostics, Alzheimer’s and Down syndrome linkages, and advances in cancer screening and biomarkers

Hardware and software solution aims to accelerate development of diagnostic and medical devices

As Gram-negative resistance becomes more complex, laboratories and clinicians are working together to turn susceptibility data into more targeted treatment decisions

We're heading to ADLM 2026